Edwards Lifesciences Corp (EW.N)

EW.N on New York Stock Exchange

73.40USD
1 Aug 2013
Price Change (% chg)

$2.02 (+2.83%)
Prev Close
$71.38
Open
$72.42
Day's High
$73.72
Day's Low
$72.31
Volume
223,569
Avg. Vol
256,301
52-wk High
$110.79
52-wk Low
$62.35

EW.N

Chart for EW.N

About

Edwards Lifesciences Corporation (Edwards Lifesciences) is focused on technologies that treat structural heart disease and critically ill patients. A pioneer in the development and commercialization of heart valve products, Edwards Lifesciences is the manufacturer of tissue heart valves and repair products used to replace or... (more)

Overall

Beta: 0.49
Market Cap (Mil.): $8,291.39
Shares Outstanding (Mil.): 112.96
Dividend: --
Yield (%): --

Financials

  EW.N Industry Sector
P/E (TTM): 21.49 67.23 37.87
EPS (TTM): 3.42 -- --
ROI: 20.93 5.02 18.70
ROE: 26.49 9.82 19.53
Search Stocks

Edwards Lifesciences beats estimates but outlook cautious

- Edwards Lifesciences Corp on Thursday reported a stronger-than-expected second-quarter profit on solid sales of its replacement heart valves, and its shares rose in after-hours trading.

25 Jul 2013

UPDATE 3-Edwards Lifesciences beats estimates but outlook cautious

* U.S. 2nd-quarter sales of Sapien heart valves at $90 mln

25 Jul 2013

Edwards Lifesciences earnings top expectations

- Edwards Lifesciences Corp on Thursday reported better-than-expected second-quarter earnings on solid sales of its replacement heart valves implanted in a less-invasive procedure than open-heart surgery.

25 Jul 2013

Edwards Lifesciences quarterly earnings rise

- Edwards Lifesciences Corp on Thursday reported higher second-quarter earnings on solid sales of its replacement heart valves implanted in a less-invasive procedure than open-heart surgery.

25 Jul 2013

Swiss equity haven may lose out as risk appetite rises

LONDON, July 22 - Signs of an impending retreat from buoyant Swiss stocks may signal the start of a new hunger for risk among investors.

22 Jul 2013

UPDATE 1-Medtronic loses heart valve patent fight in Germany

July 12 - A German court ruled against Medtronic Inc in the latest round of its patent fight with Edwards Lifesciences on Friday, judging the U.S. medical device maker's transcatheter heart valve technology infringes a patent owned by Edwards.

12 Jul 2013

Medtronic loses heart valve patent fight in Germany

July 12 - A German court ruled against Medtronic Inc in the latest round of its patent fight with Edwards Lifesciences on Friday, judging the U.S. medical device maker's heart valve technology infringes a patent owned by Edwards.

12 Jul 2013

Edwards lowers outlook as sales disappoint; shares dive

- Edwards Lifesciences Corp on Tuesday lowered its 2013 outlook due to sluggish sales at the start of the year for its less-invasive replacement heart valves, and its shares plunged 15 percent after hours.

23 Apr 2013

UPDATE 2-Edwards lowers outlook as sales disappoint; shares dive

* Shares plummet 15 percent after hours (Adds earnings details, analyst comments)

23 Apr 2013

BRIEF-Edwards Lifesciences drops 14.6 percent in extended trade

NEW YORK, April 23 - Edwards Lifesciences Corp : * Drops 14.6 percent to $70.75 in extended trade after Q1 results, outlook

23 Apr 2013

Competitors

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Stock Traders Daily
$58.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Stock Traders Daily
$495.00
Provider: S&P Capital IQ – STARS Reports
$127.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks